Skip to content

Unlocking Potential: Converging Technologies in Therapeutic Development

Get your ticket today

DATE
Tuesday, March 31
LOCATION
MaRS Discovery District
TICKET
All paid MaRS conference passes


Revolutionary technologies are changing what’s possible in the development of new medicines.

Discover how innovators are harnessing advanced tools to enhance and transform the therapeutic discovery and development process.

This full day of lightning presentations, panels and keynotes will highlight the cutting-edge health innovations made possible with tools like AI, gene editing, precision medicine and genomics, and how these technologies are changing the way we discover and develop new treatments.

In addition to venture demos, hear directly from global pharma companies on their changing strategies, approaches to R&D, as well as the emerging technologies they’re watching.

Speakers

+ more speakers to be announced


 
 

Agenda

8:30 a.m.: Registration
9:00 a.m.: Introductions
9:10 a.m.: Keynote
9:45 a.m.: Venture Presentations: Ali Punjani, Co-Founder and CEO of Structura, Lucas Siow, Co-Founder and CEO of ProteinQure, Sam Cooper, Co-Founder of Phenomic AI
10:30 a.m.: Break
10:50 a.m.: Venture Presentation: Daniel Cohen, Co-Founder and CEO of InVivo AI
11:05 a.m.: Panel Discussion: Global pharma companies discuss their changing strategies and approaches to R&D, as well as the emerging technologies they’re watching
12:00 p.m.: Lunch
1:00 p.m.: Keynote: Naheed Kurji, President and CEO of Cyclica
1:30 p.m.: Venture Presentations: Dr. Shelley Boyd, Founding President & CEO of Tracery Ophthalmics Inc. and Translatum Medicus Inc., Joseph Geraci, Co-Founder and CEO of NetraMark Corp and Natalia Martin Orozco, VP of Drug Development at Providence Therapeutics
2:40 p.m.: Break
3:00 p.m.: Venture Presentations: Brent Stead, Founder and CEO of Specific Biologics and Dr. Sheila Singh, CEO and Co-Founder of Empirica
3:40 p.m.: Closing Keynote: Brendan Frey, Founder and CEO of Deep Genomics
4:45 p.m.: Closing Remarks

Get your general, startup or investor/corporate pass